Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Sana Biotechnology, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 203
- +27 vs. Q3 2025
- Shares held
- 159.2M
- −4.42M (−2.7%) vs. Q3 2025
- Total value
- $648.8M
- +$67.0M (+11.5%) vs. Q3 2025
- New holders
- 48
- 69 more added
- Sold out
- 21
- 48 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SANA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $644.7M |
| Q1 2026 | 203 | $473.1M |
| Q4 2025 | 203 | $648.8M |
| Q3 2025 | 178 | $581.8M |
| Q2 2025 | 155 | $396.9M |
| Q1 2025 | 161 | $250.6M |
| Q4 2024 | 164 | $257.4M |
| Q3 2024 | 155 | $638.8M |
| Q2 2024 | 148 | $810.3M |
| Q1 2024 | 154 | $1.46B |
| Q4 2023 | 132 | $508.1M |
| Q3 2023 | 136 | $493.5M |
| Q2 2023 | 123 | $804.1M |
| Q1 2023 | 120 | $427.4M |
| Q4 2022 | 120 | $507.0M |
| Q3 2022 | 125 | $769.7M |
| Q2 2022 | 116 | $807.5M |
| Q1 2022 | 117 | $985.8M |
| Q4 2021 | 105 | $1.73B |
| Q3 2021 | 88 | $2.48B |
| Q2 2021 | 80 | $1.93B |
| Q1 2021 | 78 | $3.10B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Sana Biotechnology, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14,223,527 | $57.9M | 0.00% | +2,997,391+26.7% | Added |
| Flagship Pioneering Inc. | 25,001,856 | $101.8M | 31.40% | 00.0% | Unchanged |
| FMR LLC | 37,430,284 | $152.3M | 0.01% | −1,0810.0% | Reduced |
| Clearline Capital LP | 0 | $0 | 0.00% | −524,547−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −242,553−100.0% | Sold out |
| Ovata Capital Management Ltd | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −77,080−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −61,232−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −60,475−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −44,570−100.0% | Sold out |
| Employees Retirement System of Texas | 0 | $0 | 0.00% | −34,669−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −33,294−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −32,227−100.0% | Sold out |
| Jupiter Asset Management Ltd | 0 | $0 | 0.00% | −26,416−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −19,645−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −16,860−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| WJ Financial Advisors LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Smith, Moore & Co. | 0 | $0 | 0.00% | −11,250−100.0% | Sold out |
| D.A. Davidson & Co. | 0 | $0 | 0.00% | −11,220−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −1,030−100.0% | Sold out |
| Groupe la Francaise | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| CIBC Bancorp USA Inc. | – | – | – | – | Not filed |
| Pineridge Advisors LLC | – | – | – | – | Not filed |